Thursday, December 02, 2021 3:30:16 PM
Annual revenues expected to reach over $290 million, Adjusted EBITDA of at least $12 million
NEW YORK--(BUSINESS WIRE)-- DocGo (DCGO), a leading provider of last-mile mobile health services and integrated medical mobility solutions (Nasdaq:DCGO), announced today that it is updating and increasing its full-year 2021 guidance for both revenues and Adjusted EBITDA1. The Company now expects 2021 revenues in the $290 million - $300 million range, compared to the most recent guidance of $260 million. This increase is largely being driven by higher-than-expected Mobile Health revenues, reflecting the extension of certain key contracts, as well as recent contract wins. Adjusted EBITDA is now projected to be at least $12 million, compared to the most recent guidance of $10 million. The higher Adjusted EBITDA reflects the increased revenue expectation mentioned above, partially offset by continued investment in several areas, designed to position the Company for growth in 2022 and beyond.
“We are gratified that DocGo continues to deliver tremendous results as we execute on our vision of providing high quality, highly affordable healthcare for all,” said Stan Vashovsky, CEO of DocGo. "We look forward to continue to deliver shareholder value, and the highest quality of care for the patients whose lives we touch each and every day.”
DocGo Mobile Health Solutions go far beyond traditional telehealth capabilities, delivering true “last-mile” services with unique solutions that plug seamlessly into existing care ecosystems. The company’s workforce provides additional specialty medical training to its more than 3,500+ healthcare providers, giving them the skills necessary to perform more advanced procedures outside of the typical scope of work for EMTs and paramedics.
DocGo currently operates in 28 U.S. states and the UK, and has licenses pending in an additional 21 states. The company offers a continuum of care for patients with new innovations such as integrated telehealth and mobility systems which allow for greater coordination between providers at different stages of treatment or recovery from an injury or illness.
1 Adjusted EBITDA is a non-GAAP measure. See “Non-GAAP Measure” at the end of this release for a discussion of this measure, including certain limitations thereof, and a reconciliation to net income (loss), the most directly comparable GAAP measure.
Recent DCGO News
- Moore Law PLLC Investigating LOTZ, EDR, DCGO and MRCY; Shareholders are Encouraged to Contact the Firm • PR Newswire (US) • 04/26/2024 03:07:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 12:06:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:09:57 PM
- Healthcare Shares Up Big Following $36M Share Buyback Approval • AllPennyStocks.com • 01/31/2024 05:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 12:41:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:42:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:24:23 PM
- The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023 - (NASDAQ: DCGO) • PR Newswire (US) • 12/18/2023 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:17:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:12:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:05:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:58:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/04/2023 09:40:50 PM
- The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023 - (NASDAQ: DCGO) • PR Newswire (US) • 12/04/2023 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 10:28:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/28/2023 06:20:42 PM
- The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023 - (NASDAQ: DCGO) • PR Newswire (US) • 11/28/2023 10:45:00 AM
- The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023 - (NASDAQ: DCGO) • PR Newswire (US) • 11/21/2023 10:45:00 AM
- The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023 - (NASDAQ: DCGO) • PR Newswire (US) • 11/14/2023 10:45:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/14/2023 12:35:13 AM
- The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023 - (NASDAQ: DCGO) • PR Newswire (US) • 11/07/2023 06:57:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 09:45:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:15:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 10:44:24 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM